Sanofi’s Lovenox Weathers Heparin Storm; Pipeline Faces Some Setbacks

Sanofi-Aventis' antithromboticLovenox is currently enjoying a bump from the fallout of the heparin scandal, with increased sales in the U.S. where the low molecular weight heparin is produced domestically. But it may be short-lived, as Momenta and Sandoz are gearing up to re-submit their ANDA for enoxaparin